Progress Apteka Im. Ks. Jerzego Popiełuszkisp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-09-17
Share capital
5,000.00 PLN
Registered address
ul. Łomżyńska 51B, 85-863 Bydgoszcz, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 66 days late).

  • 202501/07/2026
  • 202412/06/2025
  • 202321/06/2024
  • 202216/06/2023
  • 202119/09/2022
  • 202024/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 800.10kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 45.79kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 748.41kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 275.99kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Progress Apteka Im. Ks. Jerzego Popiełuszki has been an NFZ healthcare provider since 2024. In 2026 it is performing 2 contracts with a total value of USD 351.16. All its contracts were worth USD 652.18 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmeskujawsko-pomorskie1USD 351.16
Other services provided in pharmacieskujawsko-pomorskie1USD 0.00

Authorized Representatives

Robert Mieczysław Frąckowiak – President of the Management Board
Tomasz Pięta – Management Board Member

Manner of representation

Each member of the management board is authorised to represent the company independently.

Ownership

OwnerSharesShare valueStake
Robert Mieczysław Frąckowiak
50$675.3150%
Tomasz Piętaage 49
50$675.3150%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1999-08-12.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$12,308

FAQ

Last updated: 2026-07-04